ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 176 filers reported holding ICU MED INC in Q2 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,324 | +239.0% | 86,000 | +213.9% | 0.02% | +266.7% |
| Q1 2023 | $4,520 | +233.8% | 27,400 | +218.6% | 0.01% | +200.0% |
| Q4 2022 | $1,354 | -100.0% | 8,600 | -81.8% | 0.00% | -80.0% |
| Q3 2022 | $7,108,000 | -47.6% | 47,200 | -42.8% | 0.01% | -37.5% |
| Q2 2022 | $13,562,000 | -5.7% | 82,500 | +27.7% | 0.02% | -5.9% |
| Q1 2022 | $14,383,000 | -19.2% | 64,600 | -13.9% | 0.02% | -22.7% |
| Q4 2021 | $17,801,000 | -17.5% | 75,000 | -18.8% | 0.02% | -21.4% |
| Q3 2021 | $21,564,000 | +89.5% | 92,400 | +67.1% | 0.03% | +100.0% |
| Q2 2021 | $11,381,000 | +73.1% | 55,300 | +72.8% | 0.01% | +75.0% |
| Q1 2021 | $6,574,000 | +63.0% | 32,000 | +70.2% | 0.01% | +100.0% |
| Q4 2020 | $4,032,000 | -49.6% | 18,800 | -57.1% | 0.00% | -50.0% |
| Q3 2020 | $8,005,000 | +239.3% | 43,800 | +242.2% | 0.01% | +300.0% |
| Q2 2020 | $2,359,000 | +387.4% | 12,800 | +433.3% | 0.00% | – |
| Q1 2020 | $484,000 | -78.9% | 2,400 | -73.6% | 0.00% | -100.0% |
| Q2 2019 | $2,292,000 | -86.9% | 9,100 | -88.1% | 0.00% | -89.5% |
| Q4 2018 | $17,521,000 | -70.4% | 76,300 | -63.5% | 0.02% | -68.9% |
| Q3 2018 | $59,120,000 | -65.2% | 209,089 | -66.4% | 0.06% | -34.4% |
| Q2 2018 | $169,783,000 | +117.6% | 621,600 | +101.1% | 0.09% | +9.4% |
| Q1 2018 | $78,017,000 | +8.6% | 309,100 | -7.1% | 0.08% | +7.6% |
| Q4 2017 | $71,863,000 | -12.7% | 332,700 | -24.9% | 0.08% | -18.6% |
| Q3 2017 | $82,332,000 | -18.9% | 443,000 | -24.7% | 0.10% | -25.4% |
| Q2 2017 | $101,482,000 | -4.6% | 588,300 | -15.6% | 0.13% | -12.8% |
| Q1 2017 | $106,409,000 | -2.4% | 696,849 | -5.8% | 0.15% | -13.4% |
| Q4 2016 | $108,995,000 | +16.7% | 739,700 | +0.1% | 0.17% | +4.2% |
| Q3 2016 | $93,395,000 | +4.4% | 739,000 | -6.8% | 0.16% | -2.9% |
| Q2 2016 | $89,422,000 | +2.0% | 793,100 | -5.8% | 0.17% | +1.8% |
| Q1 2016 | $87,652,000 | -4.4% | 842,000 | +3.6% | 0.17% | -16.5% |
| Q4 2015 | $91,668,000 | +9.8% | 812,800 | +6.6% | 0.20% | +0.5% |
| Q3 2015 | $83,505,000 | +26.7% | 762,600 | +10.7% | 0.20% | +32.7% |
| Q2 2015 | $65,884,000 | +16.0% | 688,734 | +13.0% | 0.15% | +24.0% |
| Q1 2015 | $56,787,000 | +27.3% | 609,700 | +11.9% | 0.12% | +12.0% |
| Q4 2014 | $44,614,000 | +24.6% | 544,741 | -2.4% | 0.11% | +10.2% |
| Q3 2014 | $35,806,000 | -8.8% | 557,900 | -13.6% | 0.10% | +6.5% |
| Q2 2014 | $39,253,000 | -10.5% | 645,500 | -11.8% | 0.09% | -12.4% |
| Q1 2014 | $43,844,000 | +15.0% | 732,201 | +22.3% | 0.10% | +15.4% |
| Q4 2013 | $38,130,000 | +42.2% | 598,500 | +51.7% | 0.09% | +40.0% |
| Q3 2013 | $26,805,000 | +46.7% | 394,600 | +55.6% | 0.06% | +35.4% |
| Q2 2013 | $18,274,000 | – | 253,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 457,964 | $85,694,000 | 4.80% |
| NUANCE INVESTMENTS, LLC | 747,515 | $139,873,000 | 4.56% |
| Tamarack Advisers, LP | 70,000 | $12,985,000 | 2.97% |
| Sandhill Capital Partners LLC | 108,625 | $20,326,000 | 2.26% |
| Partner Investment Management, L.P. | 1,381 | $258,000 | 1.85% |
| PURA VIDA INVESTMENTS, LLC | 103,320 | $19,333,000 | 1.70% |
| PFM Health Sciences, LP | 165,665 | $30,999,000 | 1.48% |
| PURA VIDA INVESTMENTS, LLC | 71,000 | $13,286,000 | 1.17% |
| KIRR MARBACH & CO LLC /IN/ | 23,286 | $4,357,000 | 1.01% |
| GW&K Investment Management, LLC | 336,119 | $62,895,000 | 0.84% |